A Phase lV Study to Evaluate the Long-term Safety and Efficacy of Clevudine in the Patients Chronically Infected With Hepatitis B Virus.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2012
At a glance
- Drugs Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 25 Jul 2012 Actual end date (1 Sep 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.